Documents

Discussions Technicals Forecast Seasonals Options

LAVA Therapeutics N.V. SEC filings and other documents

Explore the latest company documents and SEC filings from LAVA Therapeutics N.V., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 13, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 13, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 28, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Dec 10, 2024

Earnings release8-K

Q2 2024

Aug 20, 2024

Earnings release8-K

Q1 2024

May 21, 2024

Earnings release8-K

2023

Q4 2023

Mar 20, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 16, 2023

Earnings release8-K

Q2 2023

Aug 22, 2023

Earnings release8-K

Q1 2023

Jun 07, 2023

Earnings release8-K

2022

Q4 2022

Apr 11, 2023

Annual report20-F

Earnings release8-K

Q3 2022

Nov 16, 2022

Earnings release8-K

Q2 2022

Sep 13, 2022

Earnings release8-K

Study Update

Jun 16, 2022

Press release

Q1 2022

May 17, 2022

Earnings release8-K

2021

Q4 2021

Mar 24, 2022

Annual report20-F

Earnings release8-K

Q3 2021

Nov 15, 2021

Earnings release8-K

Q2 2021

Aug 16, 2021

Earnings release8-K

Q1 2021

May 20, 2021

Earnings release8-K